Our lab is conducting exciting research on the molecular programs of diabetes.
We are applying highly innovative single-cell multiomics as well as functional genomics approaches to elucidate pathways involved in endocrine cellular plasticity and diabetes pathogenesis.
We are also developing bioinformatics tools to deep analyze single-cell RNA-seq data to derive further biological insights.
We aim to discover novel targets that lead to the effective treatment of diabetes.
We employ a diverse array of state-of-the-art technologies to study pancreatic endocrine biology:
CRISPR/Cas9 mediated genetic screening
High throughput screening